Cornell Pochily Investment Advisors, Inc. Bluebird Bio, Inc. Transaction History

Cornell Pochily Investment Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 26, 2018	SELL	$88.86 - $117.49 $126,803 - $167,658	-1,427 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$99.64 - $127.59 $19,928 - $25,518	200 Added 16.3%	1,427 $223,000
Q1 2018 Apr 25, 2018	BUY	$105.8 - $150.94 $129,816 - $185,203	1,227 New	1,227 $209,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.